Marie Ange Thelu

Summary

Country: USA

Publications

  1. ncbi Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin
    Marion Levast
    Laboratory of Virology, Grenoble University Hospital, Grenoble, France
    J Med Virol 82:747-54. 2010
  2. ncbi Lack of clinical significance of variability in the internal ribosome entry site of hepatitis C virus
    Marie Ange Thelu
    Département d Hépato Gastroentérologie, Hopital Albert Michallon, Grenoble, France
    J Med Virol 72:396-405. 2004
  3. ncbi Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis
    Nathalie Sturm
    INSERM, Unité 823, Grenoble, France
    J Hepatol 53:25-35. 2010

Collaborators

  • J P Zarski
  • Vincent Leroy
  • Marion Levast
  • Nathalie Sturm
  • Sylvie Larrat
  • Guéorgui Dimitrov
  • Philippe Arvers
  • Patrice N Marche
  • Patrice Morand
  • Martine Pernollet
  • Sandrine Nicod
  • Agnès Plages
  • Xavier Camous
  • Alice Cheveau
  • Tania Dufeu-Duchesne
  • Jean Marie Seigneurin
  • Christiane Guillermet
  • Muhammad Ramzan
  • Elisabeth Brambilla
  • Paula Bonorino
  • Evelyne Jouvin-Marche

Detail Information

Publications3

  1. ncbi Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin
    Marion Levast
    Laboratory of Virology, Grenoble University Hospital, Grenoble, France
    J Med Virol 82:747-54. 2010
    ..This, just as anti-HBC status, had no clinical impact in a large cohort of hepatitis C patients. It therefore does not appear useful to screen for occult hepatitis B in these patients with this test before beginning HCV treatment...
  2. ncbi Lack of clinical significance of variability in the internal ribosome entry site of hepatitis C virus
    Marie Ange Thelu
    Département d Hépato Gastroentérologie, Hopital Albert Michallon, Grenoble, France
    J Med Virol 72:396-405. 2004
    ..Variations observed in the IRES are not a parameter of response to antiviral therapy, but the integrity of this region is a necessary condition to maintain its activity...
  3. ncbi Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis
    Nathalie Sturm
    INSERM, Unité 823, Grenoble, France
    J Hepatol 53:25-35. 2010
    ..In vitro data point out that regulatory T cells (Treg) are able to suppress HCV-specific lymphocyte proliferation and cytokine secretion but their implication in this pathology is still debated...